Proteins > Sodium channel protein type 1 subunit alpha
Page last updated: 2024-08-07 15:38:12
Sodium channel protein type 1 subunit alpha
A sodium channel protein type 1 subunit alpha that is encoded in the genome of rat. [OMA:P04774, PRO:DNx]
Synonyms
Sodium channel protein brain I subunit alpha;
Sodium channel protein type I subunit alpha;
Voltage-gated sodium channel subunit alpha Nav1.1
Research
Bioassay Publications (9)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (66.67) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Compounds (20)
Drugs with Potency Measurements
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
carbamazepine | Rattus norvegicus (Norway rat) | IC50 | 167.0000 | 1 | 2 |
racemethorphan | Rattus norvegicus (Norway rat) | IC50 | 150.6500 | 2 | 2 |
fluoxetine | Rattus norvegicus (Norway rat) | IC50 | 13.1000 | 1 | 1 |
lidocaine | Rattus norvegicus (Norway rat) | IC50 | 56.0000 | 1 | 2 |
lamotrigine | Rattus norvegicus (Norway rat) | IC50 | 82.6333 | 2 | 3 |
lidoflazine | Rattus norvegicus (Norway rat) | Ki | 0.0770 | 1 | 1 |
mexiletine | Rattus norvegicus (Norway rat) | IC50 | 47.0000 | 1 | 1 |
norfluoxetine | Rattus norvegicus (Norway rat) | IC50 | 0.8000 | 1 | 1 |
sipatrigine | Rattus norvegicus (Norway rat) | IC50 | 17.8500 | 1 | 1 |
lubeluzole | Rattus norvegicus (Norway rat) | IC50 | 2.9390 | 1 | 1 |
lifarizine | Rattus norvegicus (Norway rat) | IC50 | 0.4940 | 1 | 1 |
l 741742 | Rattus norvegicus (Norway rat) | Ki | 1.9000 | 1 | 1 |
oxytocin | Rattus norvegicus (Norway rat) | Ki | 0.0610 | 1 | 2 |
(S)-(-)-pindolol | Rattus norvegicus (Norway rat) | Ki | 0.1100 | 1 | 1 |
flunarizine | Rattus norvegicus (Norway rat) | Ki | 0.0530 | 1 | 1 |
dextromethorphan | Rattus norvegicus (Norway rat) | IC50 | 5.6500 | 2 | 2 |
tetrodotoxin | Rattus norvegicus (Norway rat) | IC50 | 0.0100 | 1 | 0 |
2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.Bioorganic & medicinal chemistry letters, , Jul-05, Volume: 14, Issue:13, 2004
Sodium channel activity and sigma binding of 2-aminopropanamide anticonvulsants.Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 9, Issue:17, 1999
Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke.Journal of medicinal chemistry, , Aug-15, Volume: 45, Issue:17, 2002
Sodium channel activity and sigma binding of 2-aminopropanamide anticonvulsants.Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 9, Issue:17, 1999